Home

The Therapy Adoption & Retention Accelerator

TARA is a technology platform that uses Artificial Intelligence (AI) to boost patient-caregiver adoption & persistency rates for specific high value therapies.

The Platform

WHY IT MATTERS

The Platform Creates Superior Shareholder Value

For emerging biopharma, every

Net of cost of product, most dollars from persistency growth flow striaght to cash earnings. This means breakout growth in product Net Present Values (NPVs) and equity valuation and non-dilutive financing.

Apart from immediate financial impact, persistency unlocks the product's strategic value drivers.

*Source: CapIQ, Reference: S&P United States SmallCap Growth Pharmaceuticals, Biotechnology & Life Sciences Index

Why TARA

Alignment with Shareholder Value

TARA is focused on equity value addition and follows a 100% at-risk model. We profit only if your patients and shareholders do better.

Built around your unique innovation & patients

By definition, every innovative therapy is unique. TARA is always deployed through a therapy specific configuration and design – giving you both scalability & product centricity.

Patient Activation & Engagement – Solved

TARA’s patient-caregiver facing {Together} interface, uses a proven proprietary design to solve the difficult problem of cognitive friction in patient activation & engagement.

Access to World Class Expertise

TARA brings together champions across multiple disciplines.

Our Team

Unmatched Intellectual Property (IP)

TARA’s underlying resiliency pathways come from its Co-Development with Harvard Medical School’s Massachusetts General Hospital (MGH). TARA’S collaborations & integrations include:

Credentialed for Quality & Security

TARA meets pharma’s compliance requirements across regions and health conditions, including Secure Storage, Encryption, Data Retention, Audit Controls & Patient Privacy.